^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    UTAA06

    i
    Other names: UTAA06, TAA6-UCAR-γδT cells, gdT cell injection targeting B7-H3 chimeric antigen receptor
    Associations

    News

    Trials
    Company:
    PersonGen Biomedicine
    Drug class:
    γδ TCR modulator, B7-H3-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over1year
    UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (clinicaltrials.gov)
    P1, N=18, Recruiting, PersonGen BioTherapeutics (Suzhou) Co., Ltd.
    New P1 trial
    |
    CD276 (CD276 Molecule)
    |
    CD276 expression
    |
    UTAA06
    over1year
    Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (clinicaltrials.gov)
    P1, N=10, Recruiting, PersonGen BioTherapeutics (Suzhou) Co., Ltd.
    New P1 trial
    |
    CD276 (CD276 Molecule)
    |
    CD276 expression
    |
    UTAA06